Microtainer Blood Collection Market

Microtainer Blood Collection Market Outlook (2023 to 2033)

The global microtainer blood collection market is projected to increase from a value of US$ 1.1 billion in 2022 to US$ 2.2 billion by 2033-end, expanding at a CAGR of 6.6% over the next ten years.

Blood collection is crucial in medicine since it assists in diagnosing various conditions, monitoring electrolytes, and treating patients and serves as a bridge between laboratories and patients. Phlebotomy involves removing blood from a patient using a needle for laboratory testing or therapeutic purposes, with clinical correlations reviewed.

• By shape, cylindrical microtainer blood collectors occupied a market share of 74.8% in 2022.
• Revenue from microtainer blood collection accounted for 15.7% share of the global blood collection devices market in 2022.

In light of the growth in lifestyle and chronic illnesses, health checkups are becoming increasingly necessary. Chronic illnesses, such as hypertension, cancer, and obesity, as well as liver, renal, cardiovascular, and lung diseases, have complicated etiologies and various morbidities.

Prevalence of lifestyle-relayed disorders is higher among those with a sedentary lifestyle, and promoting physical activity and yearly health checks is therefore critical. The need for serological testing has also skyrocketed. Improving public health requires the development of region-specific metrics and delivering timely feedback on initiatives.

Microtainer tubes collect, transport, and store blood specimens from skin punctures, primarily for infants, children, geriatrics, and critical care patients. Blood testing relies on two main collecting devices: the piston syringe and the evacuated-tube system.

• The World Health Organization and Clinical and Laboratory Standard Institute established guidelines for pre-analytical phase quality, but there are differing opinions on the order of blood collection tube draw. International guidelines now recommend the use of plastic tubes instead of glass tubes and increasing focus on the development of new additives to prevent cross-contamination.

To prevent contamination, it is crucial to draw tubes containing additives in the correct order. EDTA-containing tubes should be collected after the collection of serum or citrate-anticoagulated whole blood tubes. This prevents contamination and ensures proper mixing after removal. Pseudohypocalcemia (PHC) occurs when EDTA contamination occurs causing a reduction of serum calcium, due to its strong chelating action on divalent cations and ferric iron. It is advised to draw EDTA tubes at the end when using weaker anti-coagulants like lithium-heparin.

The interior walls of microtainers are coated with chemical agents based on their function. The microtainers with dipotassium (K2) EDTA added are used for whole-blood hematological tests. The lithium-heparin tube and gel separation tube are used in chemistry for plasma measurements. Clot activator and gel for serum separation tubes are used for serum determinations.

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Get FREE Report Sample

Why is Usage of Microtainer Blood Collection Tubes Growing Globally?

“Rising Incidence of Chronic Diseases and Ease of Sample Collection Associated with Microtainer Tubes”

Chronic diseases such as hypertension and cancer can worsen due to the adverse effect of medication or further progression of diseases. Diagnostic measures and providing timely feedback for interventions are essential for improving public health, making blood or serological testing essential. This requires a sterile, long-shelf-life microtainer to collect and store the blood.

Durable plastic tubes with flo-top collectors are utilized to facilitate sample collection and processing, ensuring optimal phlebotomy techniques. These practices encompass quality control, adherence to standards for providing quality care to patients and health workers, ensuring the availability of appropriate supplies and protective equipment, offering prophylaxis after exposure (PEP), preventing the use of contaminated phlebotomy devices, providing adequate phlebotomy training, and promoting patient collaboration.

The market is being driven by the growing emphasis on the design and development of container vials for convenience of use and handling.

• BD Microtainer, in 2023, launched a safety-engineered fingerstick collection device designed for blood collection. It features an ergonomic design for easier sampling and improved visibility. The intuitive procedure reduces training time and prevents product reuse, reducing contamination risks for patients and clinicians.

Standardizing the pre-analytic process through effective and regular training have helped reduce error rates, avoid misdiagnosis and malpractices, ensure service quality standards compliance, increase patient and employee safety, avoid labor and economic losses, and shorten turnaround times.

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

Get a Customized Version

What are the Hindrances to the Demand Growth for Microtainer Blood Collection?

“Lack of Expiration Date Awareness Regarding Collection Tubes and Inadequate Phlebotomy Training”

Variations in laboratory medicine often occur during the preanalytical phase, which is controlled by clinicians or technicians. Errors can occur at any stage, from specimen collection to laboratory processing. Being mindful of expiration dates on commercial collection tubes, particularly anticoagulants, is crucial for quality control. Expiration dates, if not checked before specimen collection, can impact laboratory results due to issues like blood sample clotting, contamination, and even misdiagnosis.

• As per the Journal of Medical Biochemistry 2018, preanalytical errors account for 60% to 70% of laboratory-based errors, causing inappropriate clinical decisions and economic losses. Improvements in reliability and standardization have reduced error rates by 10 times.

Expert phlebotomists and nurses play a significant role in organizing these processes. However, most individuals lack standardization and training opportunities. Regular phlebotomy training is necessary for new graduates and senior healthcare professionals to reduce preanalytical errors.

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Country-wise Insights

Which Factors are Responsible for the Growing Demand for Microtainer Blood Collection Tubes in the United States?

“Crucial Role of Laboratory Testing in Disease Diagnosis and Ever-rising Healthcare Expenditure”

The United States accounted for 24.9% share of the global microtainer blood collection market in 2022.

Laboratory investigations are crucial in diagnosing and managing diseases. The average daily order of tests increases with the complexity of diagnoses at discharge.

• In North America, the American Board of Internal Medicine supports the 'Choosing Wisely' campaign, which encourages the use of clinically valuable tests and the judicious allocation of resources.
• According to StatPearls Publishing (2023), misdiagnosis of blood tests can have significant consequences, impacting 70% of major decisions, including patient admission, treatment procedures, and discharge plans.

Family practitioners and internal medicine departments are the prominent groups ordering laboratory tests.

• According to the Medicare Payment Advisory Commission, Medicare is the single largest purchaser of healthcare in the United States, responsible for 23% of the US$ 743 billion spent on personal healthcare in 2019. Private health insurance accounts for a larger share of healthcare spending. Pathology investigations play a significant role, influencing 70% to 80% of healthcare decisions.

Rising expenditure on lab test diagnosis increases the number of blood collections. Medicare's choices are based on the cumulative diagnosis of serological samples from the population. There is a lot of opportunity in the United States market because of the high rate of adoption and the expanding number of players.

How are Sales of Microtainer Blood Collection Tubes Progressing in India?

“High Demand for Safe Blood and Growing Burden of Diabetes Fueling Sales of Microtainer Tubes”

India held 8% share of the global microtainer blood collection market in 2022.

• India's blood transfusion service industry is highly fragmented, with 2,760 banks collecting 12 million units annually (PLoS ONE Journal, 2021). Furthermore, the percentage of people who donate blood voluntarily remains at 80%, with the remainder relying on substitute donations by relatives or professionals posing as substitute donors. The National Blood Transfusion Council (NBTC) regulates costs, but timely access to safe blood remains a challenge.
• As per WHO (2023), India has 77 million people with diabetes, second only to China. The prevalence ranges from 5% to 17%, with a growing burden due to demographic and lifestyle changes.

Diabetes mellitus affects all segments of society, including the urban middle class and working poor. With a large proportion of the Indian population suffering from diabetes, routine blood testing for the majority of the population is required, making India a lucrative market for manufacturers of microtainer blood collection tubes.

What is the Demand Outlook for Microtainer Blood Collection in China?

“Market Driven by Rise in Cardiometabolic Diseases and Preference for Blood Biomarkers”

China accounted for 7.6% share of the global market for microtainer blood collection in 2022.

The country’s economic development, societal changes, and epidemiologic transition from infectious to chronic diseases have led to the emergence of cardiometabolic diseases. Blood biomarkers are crucial for older populations, particularly in developing countries with limited access to healthcare.

The China Health and Retirement Longitudinal Study (CHARLS) is one of the first to include blood biomarkers in a national survey. These biomarkers offer objective health information regarding pathophysiological states before clinically recognizing illnesses, disability, and death. Examining biomarkers within a large representative sample can help uncover mechanisms through which social and environmental factors influence downstream health outcomes.

Routine blood testing is a widely adopted technique, with a growing preference for the utilization of microtainer blood collection tubes. These factors are likely to fuel the microtainer blood collection market in China.

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert

I'm Available

Category-wise Insights

Why are Cylindrical Tubes Widely Preferred for Blood Collection?

“Wide Adoption of Cylindrical Microtainers Driven by Ease of Handling, Precise Volume Measurement, and Compatibility with Automated Systems”

By shape, cylindrical microtainer blood collection tubes occupied 74.8% share of the global market in 2022.

Cylindrical tubes are easier to handle and manipulate throughout the blood collection procedure. They are tiny and lightweight, making them useful for both the phlebotomist and the patient. Volume indications on cylindrical microtainers are clearly defined and generally range from 0.5 ml to 2 ml. This enables precise blood sample measurement, which is essential for several diagnostic procedures and laboratory studies.

Ease of integration of cylindrical tubes with automated blood collection systems and laboratory workflow, increased efficiency, and reduced chances of errors during sample processing are driving their demand. Use of cylindrical microtainers in blood collection has benefits in terms of convenience of use, exact volume measurement, limited sample wastage, automation compatibility, and variety. These elements contribute to greater efficiency, accuracy, and patient comfort during blood collection.

Which Product Accounts for High Revenue Globally?

“EDTA Tubes’ Role in Coagulation Prevention Contributing to Increased Sales”

By product, EDTA tubes accounted for 28.5% share of the global market in 2022.

Anticoagulants are essential in preventing clot formation in both in vitro and in vivo diagnostics. Ethylenediamine tetraacetic acid (EDTA) is a polyprotic acid that chelates calcium and other metal ions, preventing blood clotting. EDTA is recommended for hematological testing due to its preservation of cellular components and morphology. With the expansion of laboratory test volumes, EDTA has expanded its applications, stabilizing blood for various tests.

EDTA tubes are used for measuring cytokines, proteins, peptides, and cardiac markers, protecting labile molecules, and in proteomics and the study of clinical chemistry.

Where is Microtainer Blood Collection Most Commonly Done?

“Accurate Blood Collection with Microtainers at Blood Banks Ensuring Proper Tracking and Enhancing Donor Integrity”

By end user, blood banks accounted for 30.6% share of the global market in 2022.

Microtainers are a convenient and effective means of collecting blood. Blood banks frequently require significant quantities of blood samples for a variety of purposes, including blood type testing, illness screening, and transfusion compatibility testing. Microtainers enable the rapid and easy collection of tiny amounts of blood, which can simplify and enhance efficiency in large-volume settings such as blood banks.

These devices are intended to collect exact amounts of blood ranging from a few microliters to a few milliliters. This enables blood banks to reduce sample waste by collecting only the amount of blood required for certain tests or treatments. This is particularly crucial in blood banks, where every drop of donated blood is valuable and must be used efficiently.

Microtainers are usually tagged with unique identifiers like barcodes, which allow for proper sample tracking and organizing. This is critical in blood banks, where appropriate labeling and monitoring of blood samples is critical for maintaining donor integrity, assuring traceability, and minimizing mistakes or mix-ups. Hence, blood banks benefit significantly as an end user.

Competition Landscape

The microtainer blood collection sector is well-established and widely dispersed, with multiple global and local rivals offering a diverse range of products and services to consumers. To suit patients' growing needs and develop their consumer base, these businesses employ techniques such as business expansion, cooperation, and creative product launches.

• In May 2023, Greiner Bio-One, a leading manufacturer and supplier of laboratory and clinical products, extended its partnership for the 2023/24 campaign. The company’s sustainability strategy, Blue Plan, aims for climate neutrality and circularity by 2030. It launched Greiner Talks, a podcast featuring sustainability leaders, including Chairman Dale Vince.
• In October 2020, Becton, Dickinson and Company plans to invest US$ 23 million in Juncos, Puerto Rico, with nearly US$ 16 million for equipment, construction, and job retention and creation. The Department of Economic Development and Commerce is expected to grant US$ 7,015,000 in incentives for a positive return on investment.

Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the microtainer blood collection market, which are available in the full report.

Microtainer Blood Collection Industry Report Scope

Key Segments of Microtainer Blood Collection Industry Research

Product:

• Serum Separator Gel (SSG) Tubes
• EDTA Tubes
• Heparin Tubes
• Plasma Separator Tubes
• Capillary Blood Collection Tubes

Shape:

• Cylindrical
• Round-bottom

End User:

• Hospitals
• Clinics
• Diagnostic Laboratories
• Blood Banks
• Academic & Research Institutions

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa